These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3958964)

  • 21. Effects of REV 5901, a 5-lipoxygenase inhibitor and leukotriene antagonist, on pulmonary responses to platelet activating factor in the guinea-pig.
    Anderson G; Fennessy M
    Br J Pharmacol; 1988 Aug; 94(4):1115-22. PubMed ID: 3145088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Release of leukotrienes from guinea pig lung stimulated by C5ades Arg anaphylatoxin.
    Stimler NP; Bach MK; Bloor CM; Hugli TE
    J Immunol; 1982 May; 128(5):2247-52. PubMed ID: 6174625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The contractile action of platelet-activating factor on gallbladder smooth muscle.
    Parkman HP; James AN; Ryan JP
    Am J Physiol Gastrointest Liver Physiol; 2000 Jul; 279(1):G67-72. PubMed ID: 10898747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
    Chen J; Giri SN
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
    Jonsson EW
    Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
    Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
    Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of nitric-oxide synthase enhances antigen-induced contractions and increases release of cysteinyl-leukotrienes in guinea pig lung parenchyma: nitric oxide as a protective factor.
    Larsson AK; Bäck M; Hjoberg J; Dahlén SE
    J Pharmacol Exp Ther; 2005 Oct; 315(1):458-65. PubMed ID: 16024733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acid-induced release of platelet-activating factor by human esophageal mucosa induces inflammatory mediators in circular smooth muscle.
    Cheng L; Cao W; Behar J; Fiocchi C; Biancani P; Harnett KM
    J Pharmacol Exp Ther; 2006 Oct; 319(1):117-26. PubMed ID: 16807360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anatomic basis for species differences in peripheral lung strip contraction to PAF.
    Halonen M; Dunn AM; Palmer JD; McManus LM
    Am J Physiol; 1990 Aug; 259(2 Pt 1):L81-6. PubMed ID: 2382734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of platelet activating factor-induced bronchoconstriction in humans.
    Smith LJ; Rubin AH; Patterson R
    Am Rev Respir Dis; 1988 May; 137(5):1015-9. PubMed ID: 3195800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spasmogenic effect of platelet activating factor (PAF) on isolated rat stomach fundus strip.
    Levy JV
    Biochem Biophys Res Commun; 1987 Jul; 146(2):855-60. PubMed ID: 3619905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parasympathetic involvement in PAF-induced contraction in canine trachealis in vivo.
    Leff AR; White SR; Munoz NM; Popovich KJ; Shioya T; Stimler-Gerard NP
    J Appl Physiol (1985); 1987 Feb; 62(2):599-605. PubMed ID: 2881917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-activating factor-mediated contraction of rabbit lung strips: pharmacologic modulation.
    Camussi G; Montrucchio G; Antro C; Bussolino F; Tetta C; Emanuelli G
    Immunopharmacology; 1983 Aug; 6(2):87-96. PubMed ID: 6885382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of chronic administration of platelet-activating factor (PAF) in the guinea-pig and the rat.
    Pignol B; Touvay C; Pfister A; Mencia-Huerta JM; Braquet P
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():371-6. PubMed ID: 2526500
    [No Abstract]   [Full Text] [Related]  

  • 36. Epithelial modulation of thromboxane A2 and PAF involvement in IgE- and IgG-mediated guinea pig anaphylaxis.
    Bertrand C; Tschirhart E; Landry Y
    Immunopharmacology; 1991; 22(2):115-25. PubMed ID: 1761399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxofylline exerts a prophylactic effect against bronchoconstriction and pleurisy induced by PAF.
    Franzone JS; Cirillo R; Biffignandi P
    Eur J Pharmacol; 1989 Jun; 165(2-3):269-77. PubMed ID: 2776832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protection against platelet-activating factor-induced injury by interferon inducer in perfused rabbit lung.
    Huang YC; Kennedy TP; Su YF; Watkins WD; Whorton AR; Piantadosi CA
    J Appl Physiol (1985); 1993 Jan; 74(1):251-8. PubMed ID: 8444700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of LG 30435 on different platelet activating factor-induced responses.
    Subissi A; Criscuoli M
    Agents Actions Suppl; 1988; 23():201-6. PubMed ID: 3262990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms contributing to gastric motility changes induced by PAF-acether and endotoxin in rats.
    Esplugues JV; Whittle BJ
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G275-82. PubMed ID: 2919672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.